{"title":"Promoter-like activity on the minus strand supports sfRNA biogenesis in Japanese encephalitis virus","authors":"Yi-Shiuan Chen, Yi-Hsin Fan, Chih-Feng Tien, Shih-Jie Chou, Ruey-Yi Chang","doi":"10.1016/j.virol.2026.110817","DOIUrl":null,"url":null,"abstract":"<div><div>Arthropod-borne flaviviruses produce subgenomic RNAs (sfRNAs) from the highly conserved 3′-untranslated region (UTR). While most flaviviruses generate sfRNAs by resisting degradation from the host exoribonuclease XRN1, Japanese encephalitis virus (JEV) maintains sfRNA production even when XRN1 is depleted, suggesting an alternative mechanism. Using an <em>in vitro</em> RNA-dependent RNA polymerase (RdRp) assay, we identified a promoter-like element on the antigenome, designated (−)sfP, which exhibits transcriptional activity comparable to the well-characterized 5′ stem-loop A (5′-SLA) promoter of the viral genome. In contrast, the complementary strand of 5′-SLA, termed (−)SLA, located at the 3′-terminus of antigenome, displayed only weak promoter activity. Both (−)SLA and (−)sfP RNAs were found to interact with viral RdRp and a similar set of host proteins, suggesting potential roles in regulating RNA synthesis from the antigenomic template. Detection of minus-strand sfRNA by Northern blot supports the existence of replication intermediates generated through RdRp-mediated transcription rather than simple degradation products. Together, these findings reveal a previously unrecognized promoter-like activity on the JEV antigenome that may contribute to sfRNA formation and genome replication.</div></div>","PeriodicalId":23666,"journal":{"name":"Virology","volume":"617 ","pages":"Article 110817"},"PeriodicalIF":2.6000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0042682226000322","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Arthropod-borne flaviviruses produce subgenomic RNAs (sfRNAs) from the highly conserved 3′-untranslated region (UTR). While most flaviviruses generate sfRNAs by resisting degradation from the host exoribonuclease XRN1, Japanese encephalitis virus (JEV) maintains sfRNA production even when XRN1 is depleted, suggesting an alternative mechanism. Using an in vitro RNA-dependent RNA polymerase (RdRp) assay, we identified a promoter-like element on the antigenome, designated (−)sfP, which exhibits transcriptional activity comparable to the well-characterized 5′ stem-loop A (5′-SLA) promoter of the viral genome. In contrast, the complementary strand of 5′-SLA, termed (−)SLA, located at the 3′-terminus of antigenome, displayed only weak promoter activity. Both (−)SLA and (−)sfP RNAs were found to interact with viral RdRp and a similar set of host proteins, suggesting potential roles in regulating RNA synthesis from the antigenomic template. Detection of minus-strand sfRNA by Northern blot supports the existence of replication intermediates generated through RdRp-mediated transcription rather than simple degradation products. Together, these findings reveal a previously unrecognized promoter-like activity on the JEV antigenome that may contribute to sfRNA formation and genome replication.
期刊介绍:
Launched in 1955, Virology is a broad and inclusive journal that welcomes submissions on all aspects of virology including plant, animal, microbial and human viruses. The journal publishes basic research as well as pre-clinical and clinical studies of vaccines, anti-viral drugs and their development, anti-viral therapies, and computational studies of virus infections. Any submission that is of broad interest to the community of virologists/vaccinologists and reporting scientifically accurate and valuable research will be considered for publication, including negative findings and multidisciplinary work.Virology is open to reviews, research manuscripts, short communication, registered reports as well as follow-up manuscripts.